CHRONIC HEPATITIS D
Clinical trials for CHRONIC HEPATITIS D explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS D trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS D, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hepatitis delta: can switching drugs clear the virus?
Disease control Recruiting nowThis study tests whether switching from the current drug bulevirtide to a new drug called brelovitug can better control chronic hepatitis Delta. About 120 adults who have been on bulevirtide for at least 6 months will take brelovitug for 24 weeks. The main goal is to see if the v…
Matched conditions: CHRONIC HEPATITIS D
Phase: PHASE2, PHASE3 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New rapid test could transform hepatitis b and d management
Knowledge-focused Recruiting nowThis observational study aims to develop a rapid T-cell test to help manage patients with chronic hepatitis B (HBV) and hepatitis B/D (HBV/HDV) co-infection. Researchers will analyze immune responses in 300 adult patients to understand how T-cells react to the viruses. The goal i…
Matched conditions: CHRONIC HEPATITIS D
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC